These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37272863)

  • 1. Search for Origins of Anti-CRISPR Proteins by Structure Comparison.
    Sahakyan H; Makarova KS; Koonin EV
    CRISPR J; 2023 Jun; 6(3):222-231. PubMed ID: 37272863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Approaches for Prediction of Anti-CRISPR Proteins.
    Makarova KS; Wolf YI; Koonin EV
    J Mol Biol; 2023 Apr; 435(7):168036. PubMed ID: 36868398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine-learning approach expands the repertoire of anti-CRISPR protein families.
    Gussow AB; Park AE; Borges AL; Shmakov SA; Makarova KS; Wolf YI; Bondy-Denomy J; Koonin EV
    Nat Commun; 2020 Jul; 11(1):3784. PubMed ID: 32728052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.
    Wiegand T; Karambelkar S; Bondy-Denomy J; Wiedenheft B
    Annu Rev Microbiol; 2020 Sep; 74():21-37. PubMed ID: 32503371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system.
    Wandera KG; Collins SP; Wimmer F; Marshall R; Noireaux V; Beisel CL
    Methods; 2020 Feb; 172():42-50. PubMed ID: 31121300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
    Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
    Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Anti-CRISPR Proteins in Genome Editing and Biotechnology.
    Kraus C; Sontheimer EJ
    J Mol Biol; 2023 Jul; 435(13):168120. PubMed ID: 37100169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases.
    Wandera KG; Alkhnbashi OS; Bassett HVI; Mitrofanov A; Hauns S; Migur A; Backofen R; Beisel CL
    Mol Cell; 2022 Jul; 82(14):2714-2726.e4. PubMed ID: 35649413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
    Yin Y; Yang B; Entwistle S
    mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CRISPR Discovery: Using Magnets to Find Needles in Haystacks.
    Forsberg KJ
    J Mol Biol; 2023 Apr; 435(7):167952. PubMed ID: 36638909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CRISPRdb v2.2: an online repository of anti-CRISPR proteins including information on inhibitory mechanisms, activities and neighbors of curated anti-CRISPR proteins.
    Dong C; Wang X; Ma C; Zeng Z; Pu DK; Liu S; Wu CS; Chen S; Deng Z; Guo FB
    Database (Oxford); 2022 Mar; 2022():. PubMed ID: 35348649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins.
    Wang J; Dai W; Li J; Li Q; Xie R; Zhang Y; Stubenrauch C; Lithgow T
    Nucleic Acids Res; 2021 Jan; 49(D1):D630-D638. PubMed ID: 33137193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AcrIIA28 is a metalloprotein that specifically inhibits targeted-DNA loading to SpyCas9 by binding to the REC3 domain.
    Kim GE; Park HH
    Nucleic Acids Res; 2024 Jun; 52(11):6459-6471. PubMed ID: 38726868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems.
    Yin P; Zhang Y; Yang L; Feng Y
    J Mol Biol; 2023 Apr; 435(7):167996. PubMed ID: 36754343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Many (Inter)faces of Anti-CRISPRs: Modulation of CRISPR-Cas Structure and Dynamics by Mechanistically Diverse Inhibitors.
    Belato HB; Lisi GP
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
    Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
    Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent CRISPR-Cas9 inhibitors from
    Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
    Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
    Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.